Compared to the model group, a marked reduction in Ki-67 expression was observed in the tumor tissues of the PF group, Sor group, and the combination therapy group, with a progressive enhancement in the inhibition of tumor proliferation (P < 0.01). The gene discussed is MKI67; the disease is neoplasm.